Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase

被引:11
|
作者
Mancini, JA
Waugh, RJ
Thompson, JA
Evans, JF
Belley, M
Zamboni, R
Murphy, RC
机构
[1] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA
[2] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[3] Merck Frosst Ctr Therapeut Res, Dept Med Chem, Kirkland, PQ, Canada
[4] Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Denver, CO 80262 USA
关键词
D O I
10.1006/abbi.1998.0670
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukotriene A(4) (LTA(4)) hydrolase catalyzes the conversion of the unstable epoxide LTA(4) [5(S)-trans-5,6-oxido-11,14-cis-eicosatetraenoic acid] into proinflammatory LTB4. During the process of catalyzing this reaction, the enzyme is suicide inactivated by its substrate. In addition, LTA(3), an analogue of LTA(4) that lacks the C-14-C-15 double bond, is a potent suicide inhibitor of LTA(4) hydrolase, We have synthesized [H-3]LTA(3) and used this ligand to demonstrate that LTA(3) can covalently label LTA(4) hydrolase and that this labeling is specifically competed for by bestatin and LTA(3), Incubation of recombinant human LTA(4) hydrolase with LTA(3) followed by proteolysis (endoproteinase Lys-C) resulted in a peptide map with a single modified peptide defining the location of the LTA(3) covalent attachment region, This modified al-aminoacid peptide had a UV absorption spectrum corresponding to a conjugated triene chromophore which established conservation of this structural unit after covalent interaction of LTA(3) with LTA(4) hydrolase, MALDI-TOF mass spectrometric analysis of the 21-amino-acid peptide adduct revealed an abundant MH+ at mit 2658, consistent with the predicted nominal mass of the sequenced peptide with the addition of a single LTA(3) moiety, Proteolysis of LTA(4) hydrolase modified with LTA(3) was performed sequentially with endo-Asp-N and endo-Lys-C, The resulting peptide isolated by reverse-phase high-performance liquid chromatography was analyzed by mass spectroscopy revealing two related peptides, D371-K385 (m/z 2018.0) and D375-K385 (m/z 1577.8), both of which retained the elements of LTA(3). Postsource decay of mit 1577.8 resulted in an abundant ion at mit 536 and an ion of lesser abundance at mit 856 consistent with cleavage between V381 and P382 that supported assignment of the modified tyrosine residue at Y383, These results suggest nucleophilic attack of a tyrosine residue (Y383) at the conjugated triene epoxide of LTA(3) resulting in a triene ether carbinol covalent adduct. (C) 1998 Academic Press.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 50 条
  • [1] LEUKOTRIENE A3 - A POOR SUBSTRATE BUT A POTENT INHIBITOR OF RAT AND HUMAN NEUTROPHIL LEUKOTRIENE A4 HYDROLASE
    EVANS, JF
    NATHANIEL, DJ
    ZAMBONI, RJ
    FORDHUTCHINSON, AW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1985, 260 (20) : 966 - 970
  • [2] Leukotriene A4 hydrolase
    Haeggström, JZ
    Kull, F
    Rudberg, PC
    Tholander, F
    Thunnissen, MMGM
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 495 - 510
  • [3] In Silico Modeling of the Molecular Structure and Binding of Leukotriene A4 into Leukotriene A4 Hydrolase
    Paz, Paula B.
    Vega-Hissi, Esteban G.
    Estrada, Mario R.
    Garro Martinez, Juan C.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (06) : 902 - 908
  • [4] Theoretical Characterization of the Step-by-Step Mechanism of Conversion of Leukotriene A4 to Leukotriene B4 Catalysed by the Enzyme Leukotriene A4 Hydrolase
    Canyelles-Nino, Miquel
    Gonzalez-Lafont, Angels
    Lluch, Jose M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [5] Azabenzthiazole inhibitors of leukotriene A4 hydrolase
    Tanis, Virginia M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [6] Azabenzthiazole inhibitors of leukotriene A4 hydrolase
    Tanis, Virginia M.
    Bacani, Genesis M.
    Blevitt, Jonathan M.
    Chrovian, Christa C.
    Crawford, Shelby
    De Leon, Aimee
    Fourie, Anne M.
    Gomez, Laurent
    Grice, Cheryl A.
    Herman, Krystal
    Kearney, Aaron M.
    Landry-Bayle, Adrienne M.
    Lee-Dutra, Alice
    Nelson, Jay
    Riley, Jason P.
    Santillan, Alejandro, Jr.
    Wiener, John J. M.
    Xue, Xiaohua
    Young, Arlene L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7504 - 7511
  • [7] Benzthiazoles as leukotriene A4 hydrolase inhibitors
    Bacani, Genesis M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [8] Novel leukotriene A4 hydrolase inhibitors
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (01) : 91 - 95
  • [9] Leukotriene A4 hydrolase, the gatekeeper of chemotactic leukotriene B4 biosynthesis
    Tholander, F
    Rudberg, P
    Thunnissen, M
    Haeggström, JZ
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2006, 79 (1-2) : 157 - 157
  • [10] Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis
    Haeggström, JZ
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1999, 17 (1-2) : 111 - 131